- Home
- ROC vs ASRT Comparison
ROC vs ASRT Comparison
Compare ROC & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROC | ASRT |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | 82 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.8M | 76.0M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | ROC | ASRT |
|---|---|---|
| Price | $5.01 | $23.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | 32.2K | ★ 443.9K |
| Earning Date | 03-31-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.41 | $0.60 |
| 52 Week High | $7.80 | $23.46 |
Technical Indicators
Market Signals| Indicator | ROC | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 37.50 | 86.17 |
| Support Level | N/A | $0.70 |
| Resistance Level | $6.50 | N/A |
| Average True Range (ATR) | 0.45 | 0.15 |
| MACD | -0.09 | -0.07 |
| Stochastic Oscillator | 32.28 | 99.04 |
Price Performance
Historical ComparisonAbout ROC Rank One Computing Corporation Common stock
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.